Showing 6921-6930 of 10618 results for "".
- PCV Booster Coverage Declines After Schedule Changehttps://reachmd.com/news/pcv-booster-coverage-declines-after-schedule-change/2486508/Key Takeaways: An analysis reports a decline in PCV booster-dose coverage following the 2020 schedule change, based on national surveillance data. Greater declines were observed in more deprived areas, with widening disparities in uptake across local a
- Brain–Blood Signals in MDD Show Limited Concordancehttps://reachmd.com/news/brainblood-signals-in-mdd-show-limited-concordance/2486509/Key Takeaways: A review reports evidence of partial concordance between brain and blood multiomic signals in MDD, with limited overlap with GWAS-identified risk loci. Individual gene-level findings are highly variable, but recurring pathway-level theme
- New Findings on Long COVID Disability Burden in US Adultshttps://reachmd.com/news/long-covid-disability-burden-us-adults/2486485/Pooled US Household Pulse Survey data were recently used to estimate the prevalence of disabling Long COVID among adults aged ≥20, defined as current Long COVI
- Study Supports Safety, Efficacy of Subcutaneous Forehead Lift for Upper Facial Aginghttps://reachmd.com/news/study-supports-safety-efficacy-of-subcutaneous-forehead-lift-for-upper-facial-aging/2486458/A retrospective analysis published in Frontiers in Surgery evaluated the effectiveness and safety of subcutaneous forehead lift (SFL) for reducing horizontal forehead and glabellar wrinkles using the validated Wrinkle Assessment Scale (WAS). The study included 697 patients treated at a s
- IL-15 Blockade Plus Phototherapy Shows Promise in Vitiligohttps://reachmd.com/news/il-15-blockade-plus-phototherapy-shows-promise-in-vitiligo/2486454/Targeting IL-15 with ordesekimab in combination with narrowband ultraviolet B (nbUVB) phototherapy led to greater repigmentation in patients with non-segmental vitiligo, according to results from a randomized, placebo-controlled trial presented by Brett King, MD, PhD, at the American Academy of D
- NDM‑1–carrying Acinetobacter in Hospital Wastewater: Genomic Findings from Shenzhenhttps://reachmd.com/news/ndm1carrying-acinetobacter-in-hospital-wastewater-genomic-findings-from-shenzhen/2486402/A culture-based genomic survey of pre-disinfection hospital wastewater from Shenzhen, China, reports recovery of carbapenem-resistant Acinetobacter isola
- GLP‑1 Use and Body Contouring: Reporting from a 10‑Year Panniculectomy Studyhttps://reachmd.com/news/glp1-use-and-body-contouring-reporting-from-a-10year-panniculectomy-study/2486407/A retrospective cohort analysis in body-contouring surgery reported outcome-specific associations between preoperative gluc
- ILDS, WHO Launch Global Dermatology Training Hub to Address Care Gapshttps://reachmd.com/news/ilds-who-launch-global-dermatology-training-hub-to-address-care-gaps/2486380/The International League of Dermatological Societies (ILDS), in collaboration with the World Health Organization (WHO), has launched the ILDS Dermatology Training Hub, a free online platform aimed at expanding access to dermatology education worldwide. The initiati
- Final OptiTROP-Lung03 OS: Sac-TMT vs Docetaxel at ELCC 2026https://reachmd.com/news/final-optitrop-lung03-os-sac-tmt-vs-docetaxel-elcc-2026/2486358/Final survival data from the OptiTROP-Lung03
- First-in-Human Use of FDA-Cleared SINAPTIC Foot & Ankle Implant Reportedhttps://reachmd.com/news/first-in-human-use-of-fda-cleared-sinaptic-foot-ankle-implant-reported/2486339/SINTX Technologies announced what it described as the first-in-human surgical use of its U.S. FDA-cleared SINAPT